id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,comment_end_datetime,perpetual_docket,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
IRS-2025-0013-0001,IRS,IRS-2025-0013,Announcement 2025-6,Notice,Announcement,2025-01-15,2025,1,2025-01-15,2027-01-15,2027-01-16 04:59:59,0,2025-10-13 09:00:11,,1,0,09000064868c30ce
HHS-OPHS-2018-0025-0001,HHS,HHS-OPHS-2018-0025,Posting Requirement for the Exemption at 45 CFR 46.104(d)(5) of the 2018 Requirements (2022),Other,,2022-06-15,2022,6,2022-06-27,2032-06-30,2032-07-01 03:59:59,0,2026-04-27 09:00:11,,1,0,0900006485164c0a
EPA-HQ-OPP-2023-0288-0008,EPA,EPA-HQ-OPP-2023-0288,Guidance: Pesticides; Evaluation of Products for Claims against Viruses,Notice,,2024-10-10,2024,10,2024-10-10,2032-10-10,2032-10-11 03:59:59,0,2026-05-07 09:00:17,2024-23471,1,0,09000064867c4202
FDA-2011-N-0655-0041,FDA,FDA-2011-N-0655,Animal Generic Drug User Fee Act; Public Meeting; Request for Comments,Notice,Request for Comments,2026-04-17,2026,4,2026-04-17,2027-12-01,2027-12-02 04:59:59,0,2026-07-01 09:00:24,2026-07497,1,0,09000064b928930a
FDA-2026-N-0131-0001,FDA,FDA-2026-N-0131,FDA Rare Disease Innovation Hub Future Programming; Request for Comments,Notice,Request for Comments,2026-01-30,2026,1,2026-01-30,2026-12-31,2027-01-01 04:59:59,0,2026-07-08 09:00:11,2026-01903,1,0,09000064b91893ee
FHWA-2026-0826-0001,FHWA,FHWA-2026-0826,"Environmental Impact Statements; Availability, etc.: Washington County, ME",Notice,Notice of Intent,2026-07-09,2026,7,2026-07-09,2026-10-31,2026-11-01 03:59:59,0,2026-07-09 17:07:02,2026-13876,1,0,09000064b9376458
FAA-2026-7210-0001,FAA,FAA-2026-7210,"Intent to Designate as Abandoned: Abandoned Javelin Conversions, Inc. Supplemental Type Certificates",Notice,Request for Comments,2026-07-08,2026,7,2026-07-08,2027-01-04,2027-01-05 04:59:59,0,2026-07-14 09:00:28,2026-13723,1,0,09000064b9370750
FDA-2026-N-7864-0001,FDA,FDA-2026-N-7864,Data Request (DR001): Use of the pH Cycling Test Model as a Testing Procedure for Fluoride Dentifrice Drug Products in Over-the-Counter (OTC) Monograph M021: Anticaries Drug Products for Over-the-Counter Human Use,Other,Request,2026-07-28,2026,7,2026-07-28,2027-01-25,2027-01-26 04:59:59,0,2026-07-28 16:50:16,,1,0,09000064b93c7444
NCUA-2026-1420-0001,NCUA,NCUA-2026-1420,Great Horizons Federal Credit Union - Disclaimer,Notice,,2026-07-29,2026,7,2026-08-05,2026-10-08,2026-10-09 03:59:59,0,2026-07-29 19:40:35,,1,0,09000064b93d6ce0
ITC-2026-4258-0001,ITC,,"Investigations; Determinations, Modifications, and Rulings, etc.: Certain Seamless Carbon and Alloy Steel Standard, Line, and Pressure Pipe from China",Notice,,2026-08-03,2026,8,2026-08-03,2026-10-16,2026-10-17 03:59:59,0,2026-08-03 16:26:42,2026-15646,1,0,09000064b93e9d48
BIA-2022-0005-0024,BIA,BIA-2022-0005,Agency Information Collection Activities; Education Contracts Under the Johnson-O'Malley Act,Notice,,2026-01-22,2026,1,2026-01-21,2027-03-31,2027-04-01 03:59:59,0,2026-08-04 23:28:41,2026-01179,1,0,09000064b9179f6a
IRS-2026-0496-0001,IRS,IRS-2026-0496,Guidance on the employer credit for paid family and medical leave under section 45S (Notice 2026-28),Notice,Notice of Publication,2026-08-05,2026,8,2026-08-05,2026-10-16,2026-10-17 03:59:59,0,2026-08-05 19:40:14,,1,0,09000064b940001a
FCC-2026-3072-0001,FCC,,Build America: Eliminating Barriers to Wireline Deployments,Proposed Rule,,2026-08-07,2026,8,2026-08-07,2026-11-05,2026-11-06 04:59:59,0,2026-08-07 16:26:39,2026-16196,1,0,09000064b9416ef1
FDA-2025-E-0707-0005,FDA,FDA-2025-E-0707,Determination of Regulatory Review Period for Purposes of Patent Extension; DAYVIGO,Notice,Determinations,2026-08-10,2026,8,2026-08-10,2026-10-09,2026-10-10 03:59:59,0,2026-08-10 17:44:43,2026-16246,1,0,09000064b94289c5
FCC-2026-3137-0001,FCC,,"Agency Information Collection Activities; Proposals, Submissions, and Approvals",Notice,,2026-08-11,2026,8,2026-08-11,2026-10-13,2026-10-14 03:59:59,0,2026-08-11 16:26:39,2026-16298,1,0,09000064b942eb47
EPA-HQ-OPPT-2015-0436-0048,EPA,EPA-HQ-OPPT-2015-0436,"Agency Information Collection Activities; Proposals, Submissions, and Approvals: Generic Clearance for TSCA Section 4 Test Rules, Test Orders, Enforceable Consent Agreements, Voluntary Data Submissions, and Exemptions from Testing Requirement (Renewal)",Notice,Information Collection Request (ICR),2026-08-11,2026,8,2026-08-11,2026-10-13,2026-10-14 03:59:59,0,2026-08-11 16:45:13,2026-16311,1,0,09000064b942eba1
NARA_FRDOC_0001-1137,NARA,NARA_FRDOC_0001,"Agency Information Collection Activities; Proposals, Submissions, and Approvals",Notice,,2026-08-12,2026,8,2026-08-12,2026-10-13,2026-10-14 03:59:59,0,2026-08-12 16:25:45,2026-16378,1,0,09000064b9436a4c
CMS-2026-2740-0001,CMS,CMS-2026-2740,Electronic Funds Transfer Authorization Agreement (CMS-588),Notice,,2026-08-12,2026,8,2026-08-12,2026-10-13,2026-10-14 03:59:59,0,2026-08-12 18:14:49,2026-16386,1,0,09000064b9436ab0
NCUA-2026-1520-0001,NCUA,NCUA-2026-1520,NRS Community Development Federal Credit Union - Disclaimer,Notice,,2026-08-12,2026,8,2026-08-31,2026-11-08,2026-11-09 04:59:59,0,2026-08-12 19:09:32,,1,0,09000064b9437da7
FDA-2011-N-0656-1315,FDA,FDA-2011-N-0656,"Animal Drug User Fee Act; Stakeholder Consultation Meetings on the Animal Drug User Fee Act Reauthorization; Request for Notification of Stakeholder
Intent To Participate",Notice,General Notice,2026-05-11,2026,5,2026-05-11,2027-12-01,2027-12-02 04:59:59,0,2026-08-13 14:40:33,2026-09283,1,0,09000064b92cacd0
FDA-2011-N-0655-0042,FDA,FDA-2011-N-0655,"Animal Generic Drug User Fee Act; Stakeholder Consultation Meetings on the Animal Generic Drug User Fee Act Reauthorization; Request for
Notification of Stakeholder Intent To Participate",Notice,Notice of Intent,2026-05-11,2026,5,2026-05-11,2027-12-01,2027-12-02 04:59:59,0,2026-08-13 14:41:39,2026-09284,1,0,09000064b92cf91b
CMS-2026-2773-0001,CMS,CMS-2026-2773,Quality Bonus Payment Appeals (CMS-10346),Notice,,2026-08-13,2026,8,2026-08-13,2026-10-13,2026-10-14 03:59:59,0,2026-08-13 19:28:46,2026-16455,1,0,09000064b943bb72
USA-2026-HQ-0562-0001,USA,USA-2026-HQ-0562,"Agency Information Collection Activities; Proposals, Submissions, and Approvals",Notice,,2026-08-13,2026,8,2026-08-13,2026-10-13,2026-10-14 03:59:59,0,2026-08-14 17:18:13,2026-16530,1,0,09000064b9436b87
FCC-2026-3202-0001,FCC,,Review of E-Rate Program to Ensure Congress's Vision,Proposed Rule,,2026-08-14,2026,8,2026-08-14,2026-11-12,2026-11-13 04:59:59,0,2026-08-14 19:25:18,2026-16590,1,0,09000064b945712e
FCC-2026-3203-0001,FCC,,"Agency Information Collection Activities; Proposals, Submissions, and Approvals",Notice,,2026-08-14,2026,8,2026-08-14,2026-10-13,2026-10-14 03:59:59,0,2026-08-14 19:25:21,2026-16556,1,0,09000064b9457132
FS_FRDOC_0001-4420,FS,FS_FRDOC_0001,Requests for Nominations: Secure Rural Schools Resource Advisory Committees,Notice,,2026-08-14,2026,8,2026-08-14,2026-11-12,2026-11-13 04:59:59,0,2026-08-14 19:25:23,2026-16656,1,0,09000064b94571f5
CFTC-2026-1783-0001,CFTC,CFTC-2026-1783,"Agency Information Collection Activities; Proposals, Submissions, and Approvals",Notice,,2026-08-14,2026,8,2026-08-14,2026-10-13,2026-10-14 03:59:59,0,2026-08-14 19:25:25,2026-16631,1,0,09000064b94572fd
FERC-2026-4828-0001,FERC,,"Agency Information Collection Activities; Proposals, Submissions, and Approvals",Notice,,2026-08-14,2026,8,2026-08-14,2026-10-13,2026-10-14 03:59:59,0,2026-08-14 19:25:25,2026-16653,1,0,09000064b9457392
FRA-2026-1585-0001,FRA,FRA-2026-1585,"Agency Information Collection Activities; Proposals, Submissions, and Approvals",Notice,Request for Comments,2026-08-14,2026,8,2026-08-14,2026-10-13,2026-10-14 03:59:59,0,2026-08-14 19:25:25,2026-16593,1,0,09000064b9457347
FRA-2026-0039-0001,FRA,FRA-2026-0039,"Agency Information Collection Activities; Proposals, Submissions, and Approvals",Notice,Request for Comments,2026-08-14,2026,8,2026-08-14,2026-10-13,2026-10-14 03:59:59,0,2026-08-14 19:31:03,2026-16592,1,0,09000064b944e8ab
EPA-HQ-OPPT-2025-2433-0001,EPA,EPA-HQ-OPPT-2025-2433,2026 Unified Agenda of Regulatory and Deregulatory Actions,Notice,,2026-08-14,2026,8,2026-08-14,2026-10-13,2026-10-14 03:59:59,0,2026-08-15 09:01:35,2026-16608,1,0,09000064b9457348
VA-2026-VACO-0001-0328,VA,VA-2026-VACO-0001,"Agency Information Collection Activities; Proposals, Submissions, and Approvals: Application for Assumption Approval and/or Release from Personal Liability to the Government on a Home Loan [FR Doc No: 2026-16501; OMB Control No. 2900-0110]",Notice,,2026-08-13,2026,8,2026-08-13,2026-10-13,2026-10-14 03:59:59,0,2026-08-17 09:00:53,2026-16501,1,0,09000064b943bb78
VA-2026-VACO-0001-0329,VA,VA-2026-VACO-0001,"Agency Information Collection Activities; Proposals, Submissions, and Approvals: Mandatory Verification of Dependents [FR Doc No: 2026-16500; OMB Control No. 2900-0500]",Notice,,2026-08-13,2026,8,2026-08-13,2026-10-13,2026-10-14 03:59:59,0,2026-08-17 09:00:53,2026-16500,1,0,09000064b9436b88
FISCAL_FRDOC_0001-0309,FISCAL,FISCAL_FRDOC_0001,"Agency Information Collection Activities; Proposals, Submissions, and Approvals: Annual Financial Statement of Surety Companies—Schedule F",Notice,,2026-08-17,2026,8,2026-08-17,2026-10-16,2026-10-17 03:59:59,0,2026-08-17 16:25:56,2026-16725,1,0,09000064b9462d0d
FISCAL_FRDOC_0001-0310,FISCAL,FISCAL_FRDOC_0001,"Agency Information Collection Activities; Proposals, Submissions, and Approvals: Authorization Agreement for Preauthorized Payment",Notice,,2026-08-17,2026,8,2026-08-17,2026-10-16,2026-10-17 03:59:59,0,2026-08-17 16:26:07,2026-16726,1,0,09000064b9462d58
NHTSA-2026-1651-0001,NHTSA,NHTSA-2026-1651,New Car Assessment Program: Removal of Dynamic Rollover Resistance Test and Side Air Bag Out-of-Position Testing; Updates to NCAP's 10-Year Roadmap,Notice,Request for Comments,2026-08-17,2026,8,2026-08-17,2026-10-16,2026-10-17 03:59:59,0,2026-08-17 16:36:20,2026-16735,1,0,09000064b9461c63
FDA-2026-N-7757-0001,FDA,FDA-2026-N-7757,Agency Information Collection Activities; Proposed Collection; Comment Request; Third Party Disclosure and Recordkeeping Requirements for Reportable Food,Notice,60 Day Proposed Information Collection,2026-08-17,2026,8,2026-08-17,2026-10-16,2026-10-17 03:59:59,0,2026-08-17 17:13:22,2026-16714,1,0,09000064b9462da6
FDA-2026-N-8328-0001,FDA,FDA-2026-N-8328,Agency Information Collection Activities; Proposed Collection; Comment Request; Imports and Electronic Import Entries,Notice,60 Day Proposed Information Collection,2026-08-17,2026,8,2026-08-17,2026-10-16,2026-10-17 03:59:59,0,2026-08-17 17:48:14,2026-16712,1,0,09000064b9462da4
FDA-2025-E-0490-0005,FDA,FDA-2025-E-0490,Determination of Regulatory Review Period for Purposes of Patent Extension; BIZENGRI,Notice,Determinations,2026-08-17,2026,8,2026-08-17,2026-10-16,2026-10-17 03:59:59,0,2026-08-17 18:05:29,2026-16713,1,0,09000064b9462d5b
FDA-2025-E-0485-0005,FDA,FDA-2025-E-0485,Determination of Regulatory Review Period for Purposes of Patent Extension; BIZENGRI,Notice,Determinations,2026-08-17,2026,8,2026-08-17,2026-10-16,2026-10-17 03:59:59,0,2026-08-17 18:06:12,2026-16713,1,0,09000064b9463d3f
FDA-2025-E-0486-0005,FDA,FDA-2025-E-0486,Determination of Regulatory Review Period for Purposes of Patent Extension; BIZENGRI,Notice,Determinations,2026-08-17,2026,8,2026-08-17,2026-10-16,2026-10-17 03:59:59,0,2026-08-17 18:06:44,2026-16713,1,0,09000064b9463d40
FDA-2025-E-0488-0005,FDA,FDA-2025-E-0488,Determination of Regulatory Review Period for Purposes of Patent Extension; BIZENGRI,Notice,Determinations,2026-08-17,2026,8,2026-08-17,2026-10-16,2026-10-17 03:59:59,0,2026-08-17 18:07:20,2026-16713,1,0,09000064b9463d41
FDA-2025-E-0489-0005,FDA,FDA-2025-E-0489,Determination of Regulatory Review Period for Purposes of Patent Extension; BIZENGRI,Notice,Determinations,2026-08-17,2026,8,2026-08-17,2026-10-16,2026-10-17 03:59:59,0,2026-08-17 18:07:39,2026-16713,1,0,09000064b9463d42
OPM-2026-0134-0042,OPM,OPM-2026-0134,Privacy Act; Re-Established Matching Program,Notice,,2026-08-06,2026,8,2026-08-06,2026-10-27,2026-10-28 03:59:59,0,2026-08-17 18:58:03,2026-15940,1,0,09000064b9407cd1
DARS-2026-0364-0001,DARS,DARS-2026-0364,"Agency Information Collection Activities; Proposals, Submissions, and Approvals: Defense Federal Acquisition Regulation Supplement, DoD Mentor-Protege Program",Notice,,2026-08-17,2026,8,2026-08-17,2026-10-16,2026-10-17 03:59:59,0,2026-08-17 19:11:31,2026-16682,1,0,09000064b9462d14
DEA-2022-0002-0008,DEA,DEA-2022-0002,Exempt Chemical Preparations Aug 2026 (2026-16665) - DEA372,Notice,,2026-08-17,2026,8,2026-08-17,2026-10-13,2026-10-14 03:59:59,0,2026-08-17 21:26:45,2026-16665,1,0,09000064b946485f
BOEM-2026-0926-0001,BOEM,BOEM-2026-0926,"Agency Information Collection Activities; Proposals, Submissions, and Approvals: Negotiated Noncompetitive Agreements for the Use of Outer Continental Shelf Sand, Gravel, and/or Shell Resources",Notice,,2026-08-17,2026,8,2026-08-17,2026-10-16,2026-10-17 03:59:59,0,2026-08-18 09:01:12,2026-16684,1,0,09000064b9461cb0
USBC-2026-0430-0001,USBC,USBC-2026-0430,CoG 60dayfrn_published_081826,Notice,,2026-08-18,2026,8,2026-08-18,2026-10-18,2026-10-19 03:59:59,0,2026-08-18 17:03:09,2026-16791,1,0,09000064b9467195
FDA-2017-D-5974-0012,FDA,FDA-2017-D-5974,Determining Whether To Submit an ANDA or a 505(b)(2) Application; Draft Guidance for Industry; Availability,Notice,Determinations,2026-08-18,2026,8,2026-08-18,2026-10-19,2026-10-20 03:59:59,0,2026-08-18 17:24:50,2026-16837,1,0,09000064b9467538
FDA-2026-N-7914-0001,FDA,FDA-2026-N-7914,Public Meeting on Listeria monocytogenes Prevention,Other,Additional Information,2026-08-03,2026,8,2026-08-03,2026-11-02,2026-11-03 04:59:59,0,2026-08-19 09:01:12,,1,0,09000064b93e5b66
FDIC-2026-1486-0001,FDIC,,Community Reinvestment Act Regulations,Proposed Rule,,2026-08-12,2026,8,2026-08-12,2026-10-13,2026-10-14 03:59:59,0,2026-08-19 16:25:21,2026-16454,1,0,09000064b9436b80
DOL_FRDOC_0001-2697,DOL,DOL_FRDOC_0001,"Agency Information Collection Activities; Proposals, Submissions, and Approvals",Notice,,2026-08-19,2026,8,2026-08-19,2026-10-19,2026-10-20 03:59:59,0,2026-08-19 16:39:59,2026-16880,1,0,09000064b946a963
OPM_FRDOC_0001-4615,OPM,OPM_FRDOC_0001,Privacy Act; Matching Program,Notice,,2026-08-19,2026,8,2026-08-19,2026-10-20,2026-10-21 03:59:59,0,2026-08-19 16:40:05,2026-16849,1,0,09000064b946a998
DOD-2026-OS-1684-0001,DOD,DOD-2026-OS-1684,"Agency Information Collection Activities; Proposals, Submissions, and Approvals",Notice,,2026-08-19,2026,8,2026-08-19,2026-10-19,2026-10-20 03:59:59,0,2026-08-19 18:36:14,2026-16920,1,0,09000064b946a9d7
FDA-2011-N-0656-1314,FDA,FDA-2011-N-0656,Animal Drug User Fee Act; Public Meeting; Request for Comments,Notice,Request for Comments,2026-04-17,2026,4,2026-04-17,2027-12-01,2027-12-02 04:59:59,0,2026-08-20 09:01:12,2026-07498,1,0,09000064b928948d
EIB-2026-0232-0001,EIB,EIB-2026-0232,"Agency Information Collection Activities; Proposals, Submissions, and Approvals: Notice of Claim and Proof of Loss, Working Capital Guarantee",Notice,,2026-08-18,2026,8,2026-08-18,2026-10-19,2026-10-20 03:59:59,0,2026-08-20 09:01:26,2026-16845,1,0,09000064b94653e1
AMS-NOP-26-1321-0001,AMS,AMS-NOP-26-1321,"Agency Information Collection Activities; Proposals, Submissions, and Approvals: National Organic Program; Strengthening Organic Enforcement",Notice,60 Day Proposed Information Collection,2026-08-19,2026,8,2026-08-19,2026-10-19,2026-10-20 03:59:59,0,2026-08-20 09:01:27,2026-16910,1,0,09000064b946aa25
FCC-2026-3268-0001,FCC,,"Agency Information Collection Activities; Proposals, Submissions, and Approvals",Notice,,2026-08-20,2026,8,2026-08-20,2026-10-19,2026-10-20 03:59:59,0,2026-08-20 16:26:27,2026-16993,1,0,09000064b946aac1
STB-2026-2312-0001,STB,,"Control: Union Pacific Corp. and Union Pacific Railroad Co., Norfolk Southern Corp. and Norfolk Southern Railway Co.",Notice,,2026-08-20,2026,8,2026-08-20,2027-03-29,2027-03-30 03:59:59,0,2026-08-20 16:26:53,2026-17024,1,0,09000064b946c86d
FCC-2026-3270-0001,FCC,,"Agency Information Collection Activities; Proposals, Submissions, and Approvals",Notice,,2026-08-20,2026,8,2026-08-20,2026-10-19,2026-10-20 03:59:59,0,2026-08-20 16:27:26,2026-16996,1,0,09000064b946c8b7
FCC-2026-3271-0001,FCC,,"Agency Information Collection Activities; Proposals, Submissions, and Approvals",Notice,,2026-08-20,2026,8,2026-08-20,2026-10-19,2026-10-20 03:59:59,0,2026-08-20 16:27:51,2026-16997,1,0,09000064b946e17f
NSF_FRDOC_0001-3629,NSF,NSF_FRDOC_0001,"Agency Information Collection Activities; Proposals, Submissions, and Approvals: Improving Customer Experience",Notice,,2026-08-20,2026,8,2026-08-20,2026-10-19,2026-10-20 03:59:59,0,2026-08-20 16:27:53,2026-16984,1,0,09000064b946e1c2
FDA-2026-D-8561-0001,FDA,FDA-2026-D-8561,Potency Assessment of Active Immunotherapy Products; Draft Guidance for Industry; Availability,Notice,Notice of Availability,2026-08-20,2026,8,2026-08-20,2026-11-18,2026-11-19 04:59:59,0,2026-08-20 17:54:40,2026-16960,1,0,09000064b946c7f3
FDA-2026-D-8561-0002,FDA,FDA-2026-D-8561,Potency Assessment of Active Immunotherapy Products; Draft Guidance for Industry,Other,Guidance,2026-08-20,2026,8,2026-08-20,2026-11-18,2026-11-19 04:59:59,0,2026-08-20 17:59:44,,1,0,09000064b946ee4d
FCC-2026-3301-0001,FCC,,Radio Broadcasting Services: AM or FM Proposals to Change the Community of License,Notice,,2026-08-21,2026,8,2026-08-21,2026-10-20,2026-10-21 03:59:59,0,2026-08-21 16:25:50,2026-17160,1,0,09000064b9473727
SEC-2026-5190-0001,SEC,,Regulation Crypto Assets,Proposed Rule,,2026-08-21,2026,8,2026-08-21,2026-10-20,2026-10-21 03:59:59,0,2026-08-21 16:27:47,2026-17183,1,0,09000064b94738fa
RITA-2026-0001-0001,RITA,RITA-2026-0001,"Agency Information Collection Activities; Proposals, Submissions, and Approvals: Intermodal Freight Facilities Air-to-Truck and Mail Cargo Geospatial Data Update",Notice,Request for Comments,2026-08-20,2026,8,2026-08-20,2026-10-19,2026-10-20 03:59:59,0,2026-08-21 16:27:55,2026-17000,1,0,09000064b946e138
FEMA-2026-0002-0051,FEMA,FEMA-2026-0002,Proposed Flood Hazard Determinations,Notice,,2026-08-21,2026,8,2026-08-21,2026-11-19,2026-11-20 04:59:59,0,2026-08-21 17:01:46,2026-17076,1,0,09000064b94736f1
FEMA-2026-0002-0053,FEMA,FEMA-2026-0002,Proposed Flood Hazard Determinations,Notice,,2026-08-21,2026,8,2026-08-21,2026-11-19,2026-11-20 04:59:59,0,2026-08-21 17:04:23,2026-17075,1,0,09000064b94736f4
OSHA-2012-0005-0016,OSHA,OSHA-2012-0005,Cadmium in General Industry Standard; Extension of the Office of Management and Budget’s (OMB) Approval of Information Collection (Paperwork) Requirements,Notice,Request for Comments,2026-08-21,2026,8,2026-08-21,2026-10-20,2026-10-21 03:59:59,0,2026-08-21 17:09:23,2026-17151,1,0,09000064b94737b7
FEMA-2026-0002-0056,FEMA,FEMA-2026-0002,Proposed Flood Hazard Determinations,Notice,,2026-08-21,2026,8,2026-08-21,2026-11-19,2026-11-20 04:59:59,0,2026-08-21 17:09:32,2026-17074,1,0,09000064b9473724
BOEM-2026-0958-0001,BOEM,BOEM-2026-0958,"Agency Information Collection Activities; Proposals, Submissions, and Approvals: Application to be Recognized as Qualified to Bid on, Hold, or Operate a Lease or Grant on the Outer Continental Shelf",Notice,,2026-08-21,2026,8,2026-08-21,2026-10-20,2026-10-21 03:59:59,0,2026-08-21 17:11:12,2026-17149,1,0,09000064b94738c2
EPA-HQ-OW-2014-0359-0042,EPA,EPA-HQ-OW-2014-0359,"Agency Information Collection Activities; Proposals, Submissions, and Approvals: Information Request for the Underground Injection Control Program",Notice,Information Collection Request (ICR),2026-08-21,2026,8,2026-08-21,2026-10-20,2026-10-21 03:59:59,0,2026-08-21 17:53:22,2026-17096,1,0,09000064b94736ed
CISA-2026-0166-0001,CISA,CISA-2026-0166,"Agency Information Collection Activities: The Department of Homeland Security, Emergency Communications Division, Communications Assets Survey and Mapping (CASM) Tool Registration Tool",Notice,,2026-08-19,2026,8,2026-08-19,2026-10-19,2026-10-20 03:59:59,0,2026-08-21 18:19:06,2026-16877,1,0,09000064b946a9df
EPA-HQ-OPP-2022-0455-0011,EPA,EPA-HQ-OPP-2022-0455,Pesticide Tolerances: Carboxin,Rule,Final Rule,2026-08-21,2026,8,2026-08-21,2026-10-20,2026-10-21 03:59:59,0,2026-08-21 18:39:46,2026-17088,1,0,09000064b94736ee
CMS-2026-2839-0001,CMS,CMS-2026-2839,Manufacturer Submission of Average Sales Price (ASP) Data for Medicare Part B Drugs and Biologicals and Supporting Regulations in 42 CFR 414.800-806 (CMS-10110),Notice,,2026-08-21,2026,8,2026-08-21,2026-10-20,2026-10-21 03:59:59,0,2026-08-21 18:45:44,2026-17128,1,0,09000064b94736f2
EPA-HQ-OPP-2022-0743-0004,EPA,EPA-HQ-OPP-2022-0743,"Pesticide Tolerance; Exemptions, Petitions, Revocations, etc.: Calcium Carbonate",Rule,,2026-08-17,2026,8,2026-08-17,2026-10-16,2026-10-17 03:59:59,0,2026-08-22 09:02:45,2026-16720,1,0,09000064b9461c65
CMS-2026-2872-0001,CMS,CMS-2026-2872,End Stage Renal Disease Medical Evidence Report Medicare Entitlement and/or Patient Registration (CMS-2728),Notice,,2026-08-22,2026,8,2026-08-22,2026-10-20,2026-10-21 03:59:59,0,2026-08-22 18:47:51,2026-17128,1,0,09000064b94750de
FAA-2026-8786-0001,FAA,FAA-2026-8786,Airworthiness Directives: Airbus Helicopters,Proposed Rule,Request for Comment,2026-08-24,2026,8,2026-08-24,2026-10-08,2026-10-09 03:59:59,0,2026-08-24 16:54:53,2026-17209,1,0,09000064b948c1ef
FDA-2007-D-0369-2652,FDA,FDA-2007-D-0369,PSG_020816 - Draft Guidance on Brinzolamide,Other,Guidance,2026-08-24,2026,8,2026-08-24,2026-10-23,2026-10-24 03:59:59,0,2026-08-24 20:08:40,,1,0,09000064b9470607
FDA-2007-D-0369-2653,FDA,FDA-2007-D-0369,PSG_020732 - Draft Guidance on Buprenorphine,Other,Guidance,2026-08-24,2026,8,2026-08-24,2026-10-23,2026-10-24 03:59:59,0,2026-08-24 20:08:45,,1,0,09000064b94706ae
FDA-2007-D-0369-2654,FDA,FDA-2007-D-0369,PSG_204370 - Draft Guidance on Cariprazine Hydrochloride,Other,Guidance,2026-08-24,2026,8,2026-08-24,2026-10-23,2026-10-24 03:59:59,0,2026-08-24 20:08:55,,1,0,09000064b94706b0
FDA-2007-D-0369-2655,FDA,FDA-2007-D-0369,PSG_050600 - Draft Guidance on Clindamycin Phosphate,Other,Guidance,2026-08-24,2026,8,2026-08-24,2026-10-23,2026-10-24 03:59:59,0,2026-08-24 20:09:04,,1,0,09000064b94706b2
FDA-2007-D-0369-2656,FDA,FDA-2007-D-0369,PSG_215425 - Draft Guidance on Epinephrine,Other,Guidance,2026-08-24,2026,8,2026-08-24,2026-10-23,2026-10-24 03:59:59,0,2026-08-24 20:09:08,,1,0,09000064b94706b4
FDA-2007-D-0369-2657,FDA,FDA-2007-D-0369,PSG_218475 - Draft Guidance on Epinephrine Bitartrate,Other,Guidance,2026-08-24,2026,8,2026-08-24,2026-10-23,2026-10-24 03:59:59,0,2026-08-24 20:09:13,,1,0,09000064b94706b6
FDA-2007-D-0369-2658,FDA,FDA-2007-D-0369,PSG_203565 - Draft Guidance on Ferric Carboxymaltose,Other,Guidance,2026-08-24,2026,8,2026-08-24,2026-10-23,2026-10-24 03:59:59,0,2026-08-24 20:09:18,,1,0,09000064b94706b8
FDA-2007-D-0369-2659,FDA,FDA-2007-D-0369,PSG_022180 - Draft Guidance on Ferumoxytol,Other,Guidance,2026-08-24,2026,8,2026-08-24,2026-10-23,2026-10-24 03:59:59,0,2026-08-24 20:09:23,,1,0,09000064b94706ba
FDA-2007-D-0369-2660,FDA,FDA-2007-D-0369,PSG_020243 - Draft Guidance on Fluvoxamine Maleate,Other,Guidance,2026-08-24,2026,8,2026-08-24,2026-10-23,2026-10-24 03:59:59,0,2026-08-24 20:09:28,,1,0,09000064b94706bc
FDA-2007-D-0369-2661,FDA,FDA-2007-D-0369,PSG_020496 - Draft Guidance on Glimepiride,Other,Guidance,2026-08-24,2026,8,2026-08-24,2026-10-23,2026-10-24 03:59:59,0,2026-08-24 20:09:33,,1,0,09000064b94706be
FDA-2007-D-0369-2662,FDA,FDA-2007-D-0369,PSG_213876 - Draft Guidance on Hydrocortisone,Other,Guidance,2026-08-24,2026,8,2026-08-24,2026-10-23,2026-10-24 03:59:59,0,2026-08-24 20:09:38,,1,0,09000064b94706c0
FDA-2007-D-0369-2663,FDA,FDA-2007-D-0369,PSG_206185 - Draft Guidance on Latanoprost,Other,Guidance,2026-08-24,2026,8,2026-08-24,2026-10-23,2026-10-24 03:59:59,0,2026-08-24 20:09:42,,1,0,09000064b94706c2
FDA-2007-D-0369-2664,FDA,FDA-2007-D-0369,PSG_209939 - Draft Guidance on Letermovir,Other,Guidance,2026-08-24,2026,8,2026-08-24,2026-10-23,2026-10-24 03:59:59,0,2026-08-24 20:10:09,,1,0,09000064b94706c4
FDA-2007-D-0369-2665,FDA,FDA-2007-D-0369,PSG_021343 - Draft Guidance on Leuprolide Acetate,Other,Guidance,2026-08-24,2026,8,2026-08-24,2026-10-23,2026-10-24 03:59:59,0,2026-08-24 20:10:14,,1,0,09000064b94706c6
FDA-2007-D-0369-2666,FDA,FDA-2007-D-0369,PSG_021379 - Draft Guidance on Leuprolide Acetate,Other,Guidance,2026-08-24,2026,8,2026-08-24,2026-10-23,2026-10-24 03:59:59,0,2026-08-24 20:10:19,,1,0,09000064b94706c8
FDA-2007-D-0369-2667,FDA,FDA-2007-D-0369,PSG_021731 - Draft Guidance on Leuprolide Acetate,Other,Guidance,2026-08-24,2026,8,2026-08-24,2026-10-23,2026-10-24 03:59:59,0,2026-08-24 20:10:24,,1,0,09000064b94706ca
FDA-2007-D-0369-2668,FDA,FDA-2007-D-0369,PSG_021924 - Draft Guidance on Levothyroxine Sodium,Other,Guidance,2026-08-24,2026,8,2026-08-24,2026-10-23,2026-10-24 03:59:59,0,2026-08-24 20:10:29,,1,0,09000064b94706cc
FDA-2007-D-0369-2669,FDA,FDA-2007-D-0369,PSG_215029 - Draft Guidance on Lidocaine,Other,Guidance,2026-08-24,2026,8,2026-08-24,2026-10-23,2026-10-24 03:59:59,0,2026-08-24 20:10:35,,1,0,09000064b94706ce
FDA-2007-D-0369-2670,FDA,FDA-2007-D-0369,PSG_021977 - Draft Guidance on Lisdexamfetamine Dimesylate,Other,Guidance,2026-08-24,2026,8,2026-08-24,2026-10-23,2026-10-24 03:59:59,0,2026-08-24 20:10:41,,1,0,09000064b94706d0
FDA-2007-D-0369-2671,FDA,FDA-2007-D-0369,PSG_219847 - Draft Guidance on Lisdexamfetamine Dimesylate,Other,Guidance,2026-08-24,2026,8,2026-08-24,2026-10-23,2026-10-24 03:59:59,0,2026-08-24 20:10:46,,1,0,09000064b94706d2
FDA-2007-D-0369-2672,FDA,FDA-2007-D-0369,PSG_219485 - Draft Guidance on Maralixibat Chloride,Other,Guidance,2026-08-24,2026,8,2026-08-24,2026-10-23,2026-10-24 03:59:59,0,2026-08-24 20:10:51,,1,0,09000064b94706d4